GUI Enabled Optimized Approach of CNN for Automatic Diagnosis of COVID-19 Using Radiograph Images.

Researchers

Journal

Modalities

Models

Abstract

World Health Organization (WHO) proclaimed the Corona virus (COVID-19) as a pandemic, since it contaminated billions of individuals and killed lakhs. The spread along with the severity of the disease plays a key role in early detection and classification to reduce the rapid spread as the variants are changing. COVID-19 could be categorized as a pneumonia infection. Bacterial pneumonia, fungal pneumonia, viral pneumonia, etc., are the classifications of several forms of pneumonia, which are subcategorized into more than 20 forms and COVID-19 will come under viral pneumonia. The wrong prediction of any of these can mislead humans into improper treatment, which leads to a matter of life. From the radiograph that is X-ray images, diagnosis of all these forms can be possible. For detecting these disease classes, the proposed method will employ a deep learning (DL) technique. Early detection of the COVID-19 is possible with this model; hence, the spread of the disease is minimized by isolating the patients. For execution, a graphical user interface (GUI) provides more flexibility. The proposed model, which is a GUI approach, is trained with 21 types of pneumonia radiographs by a convolutional neural network (CNN) trained on Image Net and adjusts them to act as feature extractors for the Radiograph images. Next, the CNNs are combined with united AI strategies. For the classification of COVID-19 detection, several approaches are proposed in which those approaches are concerned with COVID-19, pneumonia, and healthy patients only. In classifying more than 20 types of pneumonia infections, the proposed model attained an accuracy of 92%. Likewise, COVID-19 images are effectively distinguished from the other pneumonia images of radiographs.© The Author(s), under exclusive licence to The Japanese Society for Artificial Intelligence and Springer Nature Japan KK, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.